Event basics (from official source)

• Official event: BIOSPAIN 2026
• Dates: 29 September – 1 October (year: 2026)
• Location / City / Country: Bilbao, Spain
• Venue: Bilbao Exhibition Centre (BEC)
• Venue note (official text): The event is stated to take place in Pavilion 2, Bilbao Exhibition Centre, located in Barakaldo, less than 20 minutes from downtown Bilbao.

1️⃣ Who attends (BUYERS / ATTENDEES)

BIOSPAIN is positioned as a major biotech event where the dominant “buyer-like” value is created through one-to-one meetings, investor participation, and an exhibitor-heavy ecosystem. While the event certainly includes general conference participants, the most commercially relevant attendee groups for buyer data generally cluster into the following categories:

Primary buyer/decision attendee groups (what we should target)

• Biotech leadership & BD/partnership decision-makers (e.g., Business Development, Partnerships, Strategic Alliances, Licensing, Corporate Development)
• R&D and translational research leadership (e.g., Head of R&D, Translational Medicine leads, Clinical R&D leadership where applicable)
• Clinical development and regulatory professionals (because Spain is highlighted for clinical trial initiations; buyers in this group often attend to partner)
• Investors and investment partners (the event explicitly highlights investors and licensing opportunities)
• Corporate innovation and pharma/biotech scouting teams (teams looking for external innovation, pipeline assets, licensing, and collaboration)
• Exhibitors and sponsor organizations (service providers and technology vendors that can also be buyers of partnering/intelligence and event matchmaking)
• Industry associations and cluster organizations (they often shape delegation composition and matchmaking targets)

Secondary attendees (still valuable, but less “direct buyer”)

• Researchers and scientific contributors
• Academia representatives
• Students and early-career participants (if any, depending on programming)
• General conference attendees who may not convert into direct commercial decision-makers

Our approach for BIOSPAIN should prioritize attendees most likely to act on partnership outcomes: business development, licensing, corporate development, investing, and clinical/translation leadership.

2️⃣ Where the show is happening + attendee geographic origin

• Show location: Bilbao Exhibition Centre (BEC), Bilbao / Barakaldo, Spain. The city context is important because Bilbao is described as a key biotech cluster area in Spain.
• Attendee origin (official indicators):
  • 30% of delegates came from outside Spain.
  • 32% of exhibitors were international (official text: “Of the 287 exhibitors, 32% were international.”)
• Practical geographic interpretation for buyer targeting:
  • Core: Spain (local biotech cluster representation in Basque Country, plus national hubs like Madrid, Catalonia, Andalusia as described on the site)
  • Secondary: Europe (strong international biotech attendance implied by “largest in Europe” positioning and international exhibitor share)
  • Strategic: United States presence is explicitly referenced in the broader biotech internationalization context on the site

3️⃣ Audience reach (Local / National / Global)

BIOSPAIN is not purely local. Based on the official positioning, it is: nationally important for Spain and internationally relevant across Europe and beyond via one-to-one meetings, investor participation, and international exhibitor participation.

• Local reach: Strong regional biotech connectivity (Bilbao / Basque Country + logistics and regional cluster influence)
• National reach: Major Spanish biotech trade fair and conference; it is described as the main biotechnology trade fair and conference of Spain.
• Global reach: The site highlights international delegates and international exhibitors, plus one-to-one meetings and investor participation—these elements expand the event’s practical “international deal influence.”

4️⃣ Sample buyer company names (BUYERS ONLY) + Websites

Below is a curated sample buyer list intended for prospecting. These are the types of organizations that typically align with BIOSPAIN’s partnership and investor-led model (biopharma, biotech business development, venture investors, and enabling biotech service organizations that actively scout and partner).

Important: Since we are generating a prospecting sample (not claiming these organizations are confirmed attendees), we should verify final attendee match via your client’s selection rules and any constraints you have.

Top 5 to start sending first: Roche, Novartis, Pfizer, Thermo Fisher Scientific, Seventure Partners. These cover a strong mix of pharma BD + enabling tech + investment decision-makers.

5️⃣ Job profiles, industries & event type

Job profiles to target (buyer intent roles)

• Business Development Director / Head of Business Development
• Corporate Development / Strategic Alliances Lead
• Licensing & Partnerships Manager
• Investment Director / Partner (Life Sciences VC)
• Healthcare Investments Analyst / Associate (VC or Growth)
• Translational Medicine Lead / Director
• Clinical Development Director
• Regulatory Strategy Lead
• Innovation Scouting / External Innovation Manager
• Strategic Partnerships Manager (Life Sciences Tools/Enabling Tech)

Industries most compatible with BIOSPAIN’s positioning

BIOSPAIN is a biotech-centric platform emphasizing meetings between companies, investors, and deal-makers. The most aligned industries usually cluster around:

• Biotechnology (core)
• Pharmaceuticals (pharma partnering and external innovation)
• Medical Devices (if conference tracks include enabling tech and applied health innovation)
• Research (R&D, translational collaboration)
• Market Research / Information Services (deal intelligence, analytics, life sciences data)
• Events Services / Outsourcing/Offshoring (CRO/CDMO/service ecosystem—often exhibits and partners)

Event type (how it behaves commercially)

• Biotech trade fair + conference
• One-to-one meeting program as a central mechanism (officially referenced as a standout feature)
• Investor participation
• Exhibitor-led market visibility

6️⃣ Estimated attendance (expected total footfall)

The provided official text includes a number of exhibitors (287 in the referenced context), and mentions one-to-one meetings, investors, and overall scale. However, the supplied official snippet does not provide a single explicit “total expected attendee” figure for BIOSPAIN 2026.

What we can reliably state from the official text:

• Exhibitors scale: 287 exhibitors (given in official description context for a year recap)
• International mix signals: 30% delegates outside Spain; 32% international exhibitors (from the official text)
• Commercial activity indicators: the event is described as one of the largest in the world by the number of one-to-one meetings and participating companies

Recommendation for accurate “attendance” for prospecting: if you want us to produce an attendance number in the same style as other event briefs, we need either: (a) an official BIOSPAIN 2026 attendance/footfall figure from a BIOSPAIN page, or (b) permission to use a secondary estimate model (which would not be “officially guaranteed”).

7️⃣ Key focus areas & buyer engagement

Key focus areas we should align messaging to

• Partnership formation and commercial deal flow (the event is explicitly known for one-to-one meetings)
• Licensing opportunities (the site references licensing opportunities in the event summary context)
• Investor discovery and participation
• Clinical research relevance (Spain’s clinical trial initiation leadership is described)
• Therapeutic and biotech verticals (human health dominates; food/agriculture, animal health/aquaculture, environment, and industrial biotechnology are also highlighted)
• Internationalization (international delegates and international exhibitors are highlighted)

Buyer engagement angle (what to say and how to target)

BIOSPAIN’s strongest buyer engagement is usually not “generic attendance outreach.” Instead, engagement should mirror the event’s deal logic: business development, licensing, investment, and clinical/translational partnering.

• For BD/Partnership leaders: offer a high-intent target list of decision-makers connected to biotech collaborations.
• For investors: emphasize deal discovery, early-stage/company scouting, and meeting visibility.
• For enabling tech / service providers: position as a way to meet decision-makers driving R&D, clinical operations, and innovation procurement.
• For corporate innovation: highlight pipeline-building and external innovation scanning.

8️⃣ Client-product fit note (required: we need your client website)

We can refine the “best buyers” list to match your client’s exact requirements, but we need the client website URL (the site of the client whose buyers we are identifying).

Please share:

• Client website: (required)
• What the client sells: 1–2 lines (e.g., CRO services, clinical analytics, lab equipment, lab reagents, VC fund, licensing marketplace, etc.)
• Buyer types allowed: (e.g., investors only, pharma BD only, biotech R&D only, mixed acceptable)
• Target geographies: Spain-only or EU/Global too?

How we will select “best buyers” after reviewing the client website

Once we review your client website, we will map your offering to BIOSPAIN buyer personas and then filter titles and industries accordingly. We will focus on the job families that most directly convert at a partnering/investor-focused biotech event.

Initial best-match scenarios (choose the closest one)

• If the client sells clinical, research, or development services (CRO/CDMO/service enablement): prioritize Clinical Development leaders, Translational Medicine leads, Regulatory Strategy, and BD for research services.
• If the client is an investor/fund or investment platform: prioritize Investment Director/Partner and Healthcare VC investment leads.
• If the client sells biotech tools, diagnostics, genomics, lab workflows, or enabling technology: prioritize Strategic Partnerships, Business Development for life sciences platforms, and research leadership.
• If the client is a platform for licensing/partnering/intelligence: prioritize BD/Partnership heads and corporate innovation teams that need meeting/partner data and matchmaking efficiency.

Send the client website and we will respond with: a prioritized buyer shortlist tailored to BIOSPAIN 2026, including the most relevant industries and job titles for your client’s use case.

9️⃣ Industry suggestions (aligned to an industry taxonomy)

BIOSPAIN is biotech-forward, but to improve match quality we should use the closest industry labels that correlate with biotech partnering and investment activities. Below are the most practical industry buckets to select for buyer targeting (industry taxonomy-style guidance).

Primary industry filters

• Biotechnology (core)
• Pharmaceuticals (core partnering & licensing)
• Medical Devices (if the client targets applied biotech/health tech)
• Research (translational/academic and applied R&D leaders)
• Health, Wellness & Fitness (only where relevant to specific health innovation tracks)
• Venture Capital & Private Equity (investor participation)

Secondary supporting filters (high relevance to exhibitors and deal ecosystem)

• Market Research
• Information Services
• Outsourcing/Offshoring (CRO/CDMO/service ecosystem)
• Events Services (only if your client is event-enabled or matchmaking-related)
• Professional Training & Coaching (rare, only if a biotech training vendor is involved)
• Semiconductors (generally not core unless the offering is biotech hardware needing advanced chips; keep as niche)
• Internet / Computer Software (only if client sells life sciences software platforms)

Event-industry mapping logic (how we choose)

We recommend selecting the highest-weight industries first (Biotechnology, Pharmaceuticals, Venture Capital & Private Equity, Research), then adding one supporting bucket based on your client’s product category (software, services, or enabling tools).

Quick “send first” recommendation (Buyer list strategy)

• Buyer mix: pharma/biopharma BD + enabling tech partnerships + biotech investors
• Best-fit titles: Head/Director of Business Development, Strategic Partnerships, Licensing & Alliances, Corporate Development, Investment Director/Partner, Translational Medicine Lead, Clinical Development Director
• Geography: start Spain + EU, expand to international delegates (officially 30% outside Spain)

Next step (required to finalize “best buyers” for your client)

Please paste the client website URL so we can review the product/service positioning and return: the best buyer segments, the top job titles, the most relevant industries, and a refined priority table specific to BIOSPAIN 2026 for your client’s goals.